SEC Comment Letter for RESMED INC (RMD, RSMDF) (CIK 0000943819) (RMD) — Apr 16, 2021
RESMED INC (RMD, RSMDF) (CIK 0000943819)
Date: April 16, 2021 · CIK: 0000943819 · Accession: 0000000000-21-004774
AI Filing Summary & Sentiment
File numbers found in text: 001-15317
Letter
United States securities and exchange commission logo April 16, 2021 Brett Sandercock Chief Financial Officer ResMed Inc. 9001 Spectrum Center Blvd. San Diego, CA 92123 Re:ResMed Inc. Form 10-K for the Fiscal Year Ended June 30, 2020 File No. 001-15317 Filed August 13, 2020 Dear Mr. Sandercock: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
April 16, 2021
Brett Sandercock
Chief Financial Officer
ResMed Inc.
9001 Spectrum Center Blvd.
San Diego, CA 92123
Re:ResMed Inc.
Form 10-K for the Fiscal Year Ended June 30, 2020
File No. 001-15317
Filed August 13, 2020
Dear Mr. Sandercock:
We have completed our review of your filings. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences